Bora Pharmaceuticals Co (TPE:6472) Operating Cash Flow per Share : NT$22.20 (TTM As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Bora Pharmaceuticals Co Operating Cash Flow per Share?

Bora Pharmaceuticals Co's operating cash flow per share for the three months ended in Sep. 2024 was NT$19.74. Bora Pharmaceuticals Co's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2024 was NT$22.20.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Bora Pharmaceuticals Co was -47.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 189.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 98.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Bora Pharmaceuticals Co's Operating Cash Flow per Share or its related term are showing as below:

TPE:6472' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 0.1 Med: 99 Max: 189.2
Current: 189.2

During the past 12 years, Bora Pharmaceuticals Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 189.20% per year. The lowest was 0.10% per year. And the median was 99.00% per year.

TPE:6472's 3-Year OCF Growth Rate is ranked better than
99.24% of 788 companies
in the Drug Manufacturers industry
Industry Median: 6.8 vs TPE:6472: 189.20

Bora Pharmaceuticals Co Operating Cash Flow per Share Historical Data

The historical data trend for Bora Pharmaceuticals Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bora Pharmaceuticals Co Operating Cash Flow per Share Chart

Bora Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

2.58

1.84

15.84

20.37

44.55

Bora Pharmaceuticals Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Operating Cash Flow per Share	Get a 7-Day Free Trial															6.95	10.83	11.77	-20.14	19.74

Competitive Comparison of Bora Pharmaceuticals Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Bora Pharmaceuticals Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bora Pharmaceuticals Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bora Pharmaceuticals Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bora Pharmaceuticals Co's Price-to-Operating-Cash-Flow falls into.

Bora Pharmaceuticals Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Bora Pharmaceuticals Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	4613.657	/	103.560
	=	44.55

Bora Pharmaceuticals Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Sep. 2024 )	=	Cash Flow from Operations (Q: Sep. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
	=	2068.798	/	104.826
	=	19.74

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$22.20

Bora Pharmaceuticals Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Bora Pharmaceuticals Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Bora Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bora Pharmaceuticals Co Ltd (TPE:6472) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2, Aly. 36, Lane 26, Ruiguang Road, 6th Floor, Neihu District, Taipei, TWN, 114

Website

https://www.bora-corp.com

Bora Pharmaceuticals Co Ltd is a pharmaceutical company based in Taiwan. It covers the pharmaceutical supply chain from research and development to sales and distribution. The main activities of the Company focus on manufacturing and selling generic, brand, and over-the-counter (OTC) drugs, contract development and manufacturing (CDMO), and developing and selling consumer healthcare products. The Group operates in three reportable segments; Commercial sales segment, Contract Development & Manufacturing Organization segment, and Other segment. The majority of revenue is derived from the Commercial sales segment. Geographically, the company operates in the USA which derives key revenue, Europe, Taiwan, and other regions.

Bora Pharmaceuticals Co Headlines

No Headlines